Stephen A. Spearman
Profile
Stephen A.
Spearman is Vice President of Development and Production for Diosynth RTP, Inc. Previously, he worked at Ciba-Geigy.
He joined Pharmacopeia, Inc. in 1996 and served as Chief Operating Officer.
Dr. Spearman has over 28 years of experience including many positions of senior and executive management.
Former positions of Stephen A. Spearman
| Companies | Position | End |
|---|---|---|
Diosynth RTP, Inc.
 Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Corporate Officer/Principal | 2011-04-28 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Diosynth RTP, Inc.
Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Stephen A. Spearman
